Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

227
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
227
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

146
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
146
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

185
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
185
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.1K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistics and AI - A Fireside Conversation.

Harvard data science review·2026
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same author

SEMIPARAMETRIC ANALYSIS OF INTERVAL-CENSORED DATA SUBJECT TO INACCURATE DIAGNOSES WITH A TERMINAL EVENT.

The annals of applied statistics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Asymptotic Inference for Multi-Stage Stationary Treatment Policy with Variable Selection.

Journal of machine learning research : JMLR·2026
Same journal

Classification Under Local Differential Privacy with Model Reversal and Model Averaging.

Journal of machine learning research : JMLR·2026
Same journal

Sparse Semiparametric Discriminant Analysis for High-dimensional Zero-inflated Data.

Journal of machine learning research : JMLR·2026
Same journal

Heterogeneity-aware Clustered Distributed Learning for Multi-source Data Analysis.

Journal of machine learning research : JMLR·2026
Same journal

Unsupervised Tree Boosting for Learning Probability Distributions.

Journal of machine learning research : JMLR·2026
Same journal

A Two-Stage Penalized Least Squares Method for Constructing Large Systems of Structural Equations.

Journal of machine learning research : JMLR·2026
Same journal

Bayesian Multinomial Logistic Normal Models through Marginally Latent Matrix-T Processes.

Journal of machine learning research : JMLR·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Learning Optimal Dynamic Treatment Regimens Subject to Stagewise Risk Controls.

Mochuan Liu1, Yuanjia Wang2, Haoda Fu3

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Journal of Machine Learning Research : JMLR
|December 19, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new framework for dynamic treatment regimens (DTRs) to balance treatment benefits and risks for chronic diseases like type 2 diabetes. The method optimizes sequential treatment decisions while managing potential adverse events.

Keywords:
Acute adverse eventsBenefit-risk tradeoffDynamic treatment regimensPrecision medicineWeighted support vector machine

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Related Experiment Videos

Last Updated: Jan 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Area of Science:

  • * Biostatistics and Health Informatics
  • * Clinical Decision Support Systems
  • * Personalized Medicine

Background:

  • * Dynamic treatment regimens (DTRs) aim to personalize sequential treatment strategies.
  • * Chronic diseases like type 2 diabetes (T2D) present complex benefit-risk trade-offs in treatment.
  • * Aggressive treatments may increase rewards but also elevate risks of adverse events.

Purpose of the Study:

  • * To propose a novel weighted learning framework, benefit-risk dynamic treatment regimens (BR-DTRs).
  • * To address the critical benefit-risk trade-off in individualized sequential treatment decision-making.
  • * To develop DTRs that constrain induced risk within pre-specified limits at each stage.

Main Methods:

  • * Utilized a backward learning procedure for treatment rule estimation.
  • * Employed a weighted support vector machine with a modified smooth constraint.
  • * Incorporated a pre-specified risk constraint at each treatment stage.

Main Results:

  • * Demonstrated Fisher consistency of the proposed BR-DTRs.
  • * Established convergence rates for both value and risk functions.
  • * Validated performance through extensive simulations and a real-world T2D patient study.

Conclusions:

  • * The BR-DTR framework effectively manages benefit-risk trade-offs in sequential treatments.
  • * The proposed method offers a computationally efficient and theoretically sound approach.
  • * Applicable to optimizing treatments for chronic diseases, including T2D.